Evidence map›Paper›PMID 35496511›Full record

ArticleRSC advances2020

A novel nanozyme based on selenopeptide-modified gold nanoparticles with a tunable glutathione peroxidase activity.

Dechen Zhang, Na Shen, Junrong Zhang, Jinming Zhu, Yi Guo, Li Xu

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Geroprotective effects of GdVOBiogerontology · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Selenium in Peptide Chemistry.Molecules (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dechen ZhangKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012 P. R. China xuli@jlu.edu.cn.
Na ShenKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012 P. R. China xuli@jlu.edu.cn.
Junrong ZhangKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012 P. R. China xuli@jlu.edu.cn.
Jinming ZhuChina-Japan Union Hospital of Jilin University Changchun 130033 P. R. China.
Yi GuoKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012 P. R. China xuli@jlu.edu.cn.
Li XuKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012 P. R. China xuli@jlu.edu.cn.ORCID https://orcid.org/0000-0001-5378-8020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we successfully prepared a selenium-containing pentapeptide (Sec-Arg-Gly-Asp-Cys)-modified gold nanozyme that exhibited glutathione peroxidase (GPx) activity. The nanozyme catalyzed the reduction of H

Identifiers

PMID35496511
PMCPMC9049964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.